GlassScriptPhysician profile
Emily L Arch
NPI 1376701623
$9,912.54
in general payments reported to CMS, 2019-2025
33 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,560 · 2020: $647 · 2021: $1,032 · 2022: $1,645 · 2023: $1,555 · 2024: $1,828 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,982 · Education: $45.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,982.08 |
| Education | $45.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,957.01 | 2019-2025 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $968.68 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Pfizer INC. | $836.16 | 2019-2025 | |
| Janssen Biotech, INC. | $761.50 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $648.34 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $517.24 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $450.75 | 2019-2024 | Dupixent |
| Galderma Laboratories, L.P. | $440.96 | 2019-2025 | Oracea, Epsolay, Aklief |
| Mayne Pharma Commercial LLC | $399.63 | 2022-2025 | |
| Leo Pharma INC. | $346.55 | 2019-2025 | Adbry |
| Lilly USA, LLC | $310.35 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $306.94 | 2019-2025 | Cabtreo, Siliq, Arazlo |
| Incyte Corporation | $289.98 | 2021-2025 | Opzelura |
| Ucb, INC. | $274.58 | 2019-2025 | Bimzelx |
| Amgen INC. | $233.39 | 2020-2025 | Otezla, Otezla |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $225.65 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $128.54 | 2023-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.46 | 2023-2025 | Spevigo, Cyltezo |
| Epi Health, LLC | $119.23 | 2019-2022 | |
| Fresenius Kabi USA, LLC | $104.71 | 2023-2025 | Idacio |
| Almirall LLC | $85.92 | 2019-2020 | |
| Dermira, INC. | $79.21 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $61.63 | 2023-2024 | Sotyktu |
| Mylan Pharmaceuticals INC. | $54.89 | 2019 | |
| Organon LLC | $27.94 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $26.11 | 2021 | |
| Botanix Sb INC | $25.23 | 2025 | Sofdra |
| Celgene Corporation | $23.27 | 2019 | |
| Sandoz INC. | $21.33 | 2019 | |
| Organogenesis INC. | $18.75 | 2023 | Puraply |
| Dusa Pharmaceuticals, INC. | $16.46 | 2019 | |
| Encore Dermatology INC. | $12.32 | 2019 | |
| Mission Pharmacal Company | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Arch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.